Terazosin Capsule
Product Images NDC 70518-0074

6 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 70518-0074). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Fig 1)

Structure (Fig 1)
Chemical structure diagram of Terazosin Hydrochloride showing its molecular arrangement with labeled atoms and bonds.*
FDA Label Image

Figure2 (Fig 2)

Figure2 (Fig 2)
A two-panel chart comparing placebo and Terazosin effects over three months. Left panel shows mean change in total symptom score from baseline, with Terazosin group showing a greater decrease than placebo. Right panel displays mean increase in peak flow rate (mL/sec) from baseline, where Terazosin group exhibits a higher increase compared to placebo. Sample sizes are N=54-55 per group.*
FDA Label Image

Figure3 (Fig 3)

Figure3 (Fig 3)
A line graph depicting the mean change from baseline over time in months. The x-axis represents months from 0 to 30, and the y-axis shows the mean change from baseline with values ranging approximately from 0 to -7. Data points are marked with circles, and several points are indicated with asterisks, suggesting statistical significance at those points.*
FDA Label Image

Figure4 (Fig 4)

Figure4 (Fig 4)
A line graph depicting the mean change from baseline in a variable measured in nL/sec over a 30-month period. Data points are plotted at various months, showing an overall upward trend with error bars and several points marked with an asterisk indicating statistical significance.*
FDA Label Image

Mm1 (Terazosin 2mg 70518 0074 00)

Mm1 (Terazosin 2mg 70518 0074 00)
Terazosin 2 mg capsule label shows a pack quantity of 30 units. The label highlights the generic name Terazosin Hydrochloride and states it is an oral human prescription drug by RemedyRepack Inc. Additional details include NDC number 70518-0074, manufacturing by Cadista Pharma, and storage instructions.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Terazosin Capsule 2 mg oral capsules packaging label showing a quantity of 30 capsules. The label includes the NDC number 70518-0074-01 and identifies RemedyRepack Inc. as the repackager. It advises protecting the capsules from light and moisture and provides storage temperature instructions and a manufacturer name, Cadista Pharma, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.